Effect of Dose Modifications on Response to Duvelisib in Patients with Relapsed/Refractory (R/R) CLL/SLL in the DUO Trial
Authors:
- Ian FlinnIFIan Flinn
- Marco MontilloMMMarco Montillo
- Árpád IllésÁIÁrpád Illés
- Gabriel EtienneGEGabriel Etienne
- Julio DelgadoJDJulio Delgado
- Bryone KussBKBryone Kuss
- Constantine TamCTConstantine Tam
- Fritz OffnerFOFritz Offner
- Francesc BoschFBFrancesc Bosch
- Matthew DavidsMDMatthew Davids
- Ulrich JägerUJUlrich Jäger
- Paolo GhiaPGPaolo Ghia
- 1 September 2019
- journal article
- abstracts
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 19, S273-S274